Patents Examined by Genevieve S Alley
  • Cosmetic product to prevent body odor with an improved long-term effect
    Patent number: 10980721
    Abstract: The present disclosure relates to cosmetic agents, which in addition to a deodorant agent contain a combination of special aromatic alcohols and certain menthyl compounds. These agents have a long-lasting deodorizing effect. The present disclosure also relates to a cosmetic product that includes the cosmetic agent as contemplated herein, as well as at least one propellant. The present disclosure also relates to the use of the agent as contemplated herein to treat body odor, as well as the use of a combination of aromatic alcohol and menthyl compounds to improve the odor-inhibiting effect of cosmetic agents over a period of from about 24 to about 48 hours.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: April 20, 2021
    Assignee: Henkel AG & Co. KGaA
    Inventor: Thomas Doering
  • Cosmetic product comprising a metal can, and the contents of same
    Patent number: 10980333
    Abstract: Disclosed is a cosmetic product comprising a metal can which comprises a metal container (A) which has a rotary thread (A?) and contains a cosmetic preparation as well as a lid (D) having a thread (D?) and being of the same metal as the container. The lid can be screwed onto/unscrewed from the container by means of threads (D?) and (A?) via rotational movement. The cosmetic preparation comprises an emulsion of one or more hydrophilic phases and one or more lipophilic phases. The one or more lipophilic phases comprise at least one lipid having a spreading coefficient at 25° C. of no more than 700 mm2/10 minutes, at least one lipid having a dropping point of >30° C., and at least one monovalent and/or polyvalent alcohol in a total amount of at least 3 wt. %.
    Type: Grant
    Filed: February 8, 2016
    Date of Patent: April 20, 2021
    Assignee: BEIERSDORF AG
    Inventors: Anja Bauer, Volker Kallmayer, Peter Steidle, Klaus-Peter Stange
  • Dendritic macroporous hydrogels prepared by crystal templating
    Patent number: 10982068
    Abstract: The present invention includes a hydrogel and a method of making a porous hydrogel by preparing an aqueous mixture of an uncrosslinked polymer and a crystallizable molecule; casting the mixture into a vessel; allowing the cast mixture to dry to form an amorphous hydrogel film; seeding the cast mixture with a seed crystal of the crystallizable molecule; growing the crystallizable molecule into a crystal structure within the uncrosslinked polymer; crosslinking the polymer around the crystal structure under conditions in which the crystal structure within the crosslinked polymer is maintained; and dissolving the crystals within the crosslinked polymer to form the porous hydrogel.
    Type: Grant
    Filed: October 9, 2019
    Date of Patent: April 20, 2021
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Scott Zawko, Christine Schmidt
  • Solid pharmaceutical tablet
    Patent number: 10980831
    Abstract: The invention relates to a solid pharmaceutical tablet for oral delivery, the tablet comprising calcium carbonate in an amount of more than 30% by weight of the tablet and organic water-insoluble components in an amount of more than 20% by weight of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing the organic water-insoluble components, and wherein the tablet is adapted to release more than 80% of the calcium carbonate within 5 minutes of mastication.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: April 20, 2021
    Assignee: FERTIN PHARMA A/S
    Inventor: Jesper Neergaard
  • Pathogen eliminating article and methods of manufacturing and using the same
    Patent number: 10959426
    Abstract: An antimicrobial article including a first layer of a shielding material having a first surface and an opposite second surface. The article also includes a core material coupled to the first surface. The core material includes an antimicrobial material configured to eliminate pathogens on the second surface without contacting the pathogens.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: March 30, 2021
    Assignee: CLAW BIOTECH HOLDINGS LLC
    Inventors: Jeffery L. Dudding, Amod P. Paranjpe
  • Dry acid concentrate in granulate form
    Patent number: 10918600
    Abstract: The present invention relates to a novel dry acid concentrate (DAC) for a dialysis liquid and to a dialysis liquid, which is made from said concentrate, and which may be used for purifying blood. The invention further relates to a method of making the dry acid concentrate as well as the dialysis liquid. It also relates to a container (10) comprising said acid concentrate, and which is—in certain embodiments—specially adapted to a dialysis unit.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: February 16, 2021
    Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Thierry Eyrard, Philippe Laffay, Benoit Luaire
  • Binary compositions as disruptors of orco-mediated odorant sensing
    Patent number: 10791739
    Abstract: In one aspect, the invention relates to binary compositions that disrupt ORco-mediated odorant sensing. In particular, compounds and compositions are provided that can inhibit sensory (e.g., host targeting) functions in organisms that express ORco receptors such as airborne insects, e.g., mosquitoes, and ticks. Method of employing such agents, and articles incorporating the same, are also provided. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: October 6, 2020
    Assignee: Vanderbilt University
    Inventors: Laurence J. Zwiebel, Ian M. Romaine, Sam Ochieng, Alex Gregory Waterson, Gary A. Sulikowski
  • Water-based cosmetic composition comprising an effect pigment and a cosmetic active
    Patent number: 10765611
    Abstract: The disclosure relates to an aqueous cosmetic composition that includes at least one effect pigment is present up to about 0.02 wt %, an emulsion of at least one oil and at least one surfactant, and at least one active selected to provide one or more benefits, including, but not limited to brightening/whitening, improvement of skin tone, blemish control or reduction, reduction of redness, anti-aging, and hydration, in an aqueous solvent. The composition may include a thickener and a preservative. Methods include forming the composition and applying the composition to the skin to provide an instant “glowing” or “brightening” effect.
    Type: Grant
    Filed: October 18, 2017
    Date of Patent: September 8, 2020
    Assignee: L'Oreal
    Inventor: Catherine Chiou
  • Topical compositions and methods for making and using same
    Patent number: 10729667
    Abstract: The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: August 4, 2020
    Inventors: Bhushan Hardas, Donna Dalton, Petra Scheppler, Anja Buch, Peter Boderke
  • Topical compositions and methods for making and using same
    Patent number: 10695303
    Abstract: The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: June 30, 2020
    Assignee: Sebela Ireland Limited
    Inventors: Bhushan Hardas, Donna Dalton
  • Composition comprising a pesticide and a hydroxyalkyl polyoxylene glycol ether
    Patent number: 10694742
    Abstract: A composition having a pesticide and a hydroxyalkyl polyoxylene glycol ether of the general formula (I) where R1 is a saturated or unsaturated, linear or branched alkyl having 6 to 18 carbon atoms; R2 is ethylene, propylene, butylene or a mixture thereof; R3 is a saturated or unsaturated, linear or branched alkyl having 6 to 18 carbon atoms; and n has a value of from 1 to 100. The composition may be used as an adjuvant in in pesticide-comprising spray mixtures. In a method for controlling phytopathogenic fungi and/or undesirable plant growth and/or undesirable insect or mite infestation and/or for regulating the growth of plants, the composition is allowed to act on the respective pests, the habitat thereof or the plants to be protected from the respective pest, on the soil and/or on undesirable plants and/or the crop plants and/or the habitat thereof. Seed may also include the composition.
    Type: Grant
    Filed: May 4, 2015
    Date of Patent: June 30, 2020
    Assignee: BASF SE
    Inventors: Martin Semar, Ingo Fleute-Schlachter, Hans-Christian Raths, Markus Kalt, Rainer Berghaus
  • Prevention of protein glycation using lysine supplements
    Patent number: 10695368
    Abstract: A method of preventing protein glycation using a supplement may comprise: administering a supplement comprising lysine and zinc; monitoring a concentration of glucose before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the concentration of glucose found in the bio-sample.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: June 30, 2020
    Assignee: Lysulin, Inc.
    Inventor: John Burd
  • Acid compositions and uses thereof
    Patent number: 10667520
    Abstract: The present disclosure provides compositions and methods for using the compositions to treat animal facilities. In particular, the composition comprises a metal sulfate, an inorganic acid having a pKa of less than 1, and one or more organic acids.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: June 2, 2020
    Assignee: Chemtrade Solutions, LLC
    Inventor: Rex Johns
  • Prevention of protein glycation using lysine/zinc supplements
    Patent number: 10653720
    Abstract: A method of preventing protein glycation using a supplement may comprise: administering a supplement comprising lysine and zinc; monitoring a concentration of glucose before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the concentration of glucose found in the bio-sample.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: May 19, 2020
    Assignee: Lysulin, Inc.
    Inventor: John Burd
  • Inhibiting chronic blood and nephrological disorders using lysine-based supplements
    Patent number: 10656166
    Abstract: A method of affecting blood chemistry using a supplement may comprise: measuring a blood glucose level; determining a blood glucose level; and if the blood glucose level exceeds a threshold, administering a supplement comprising lysine, zinc, and vitamin C.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: May 19, 2020
    Assignee: Lysulin, Inc.
    Inventor: John Burd
  • Composition for preventing hair loss or promoting hair growth, containing ginseng-derived exosome-like vesicles
    Patent number: 10653616
    Abstract: Disclosed in the present specification are: a composition for preventing hair loss or promoting hair growth, containing ginseng-derived exosome-like vesicles; and a method for preparing the composition. The ginseng-derived exosome-like vesicles can have a diameter of 20-500 nm and can be isolated from ginseng root. The composition contains ginseng-derived exosome-like vesicles as active ingredients, thereby having an effect of inducing hair growth by activating dermal papilla cells (DPCs).
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: May 19, 2020
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Eun-Jeong Choi, Yonghee Lee, Seung Hyun Shin, Kyeonghwan Hwang, Eun-Gyung Cho, Tae Ryong Lee
  • Method for adjusting hardness of stick-shaped base material comprising lipid peptide compound
    Patent number: 10639263
    Abstract: A method for adjusting hardness of a stick-shaped base material including a lipid peptide compound. A method for adjusting hardness of a gelled solid base material for skin external application including a surfactant, water, and lipid peptide compound including compounds of formulae (1) or similar, wherein R1 is a C9-23 aliphatic group, R2 is a hydrogen atom or similar, and R3 is a —(CH2)n-X group, n is a number from 1 to 4, and X is amino group, the method including adding a pH adjuster to a solution in which the material is dissolved, or a solution including a surfactant, water, and lipid peptide compound including at least one of compounds of formulae (1) to (3) or pharmaceutically usable salts thereof, to adjust the pH of the solution to a weak acidic to neutral range, causing gelation of the solution to form a solid base material for skin external application.
    Type: Grant
    Filed: June 14, 2016
    Date of Patent: May 5, 2020
    Assignee: NISSAN CHEMICAL INDUSTRIES, LTD.
    Inventor: Tsubasa Kashino
  • Compounds and medical devices activated with solvophobic linkers
    Patent number: 10632207
    Abstract: The present disclosure relates to compounds and medical devices activated with a solvophobic material functionalized with a first reactive member and methods of making such compounds and devices.
    Type: Grant
    Filed: November 13, 2015
    Date of Patent: April 28, 2020
    Assignee: Sofradim Production
    Inventors: Sébastien Ladet, Philippe Gravagna
  • Method for producing a plant life enhancing product
    Patent number: 10624350
    Abstract: A method for producing a plant life enhancing product is described. The method includes: (i) anaerobically digesting agricultural residue to produce an anaerobically activated organic residue and an ammonia-enriched water; (ii) aerobically digesting the ammonia-enriched water to produce an aerobically activated organic residue; and (iii) blending the anaerobically activated organic residue with the aerobically activated organic residue to produce the plant life enhancing product.
    Type: Grant
    Filed: January 16, 2018
    Date of Patent: April 21, 2020
    Inventor: Christopher R. Ott
  • Process for manufacturing dry powder blends
    Patent number: 10617646
    Abstract: The invention relates to processes for dry powder blending. Specifically the invention relates to dry powder blending of pharmaceutical and non-pharmaceutical solid particulate matter and powders. More specifically the invention relates to dry powder blending of microparticles, and to dry powder blends for use as pharmaceuticals. In particular, the present invention relates to a process of preparing a dry microparticulate powder blend comprising one or more micronized active pharmaceutical ingredient(s) (API) and optionally, one or more micronized or non-micronized pharmaceutically acceptable carrier(s) and/or excipient(s), wherein the process comprises the steps of ‘pulsating blending’ of the micronized active pharmaceutical ingredient(s) and the pharmaceutically acceptable carrier(s) and/or excipient(s).
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: April 14, 2020
    Assignee: LUPIN ATLANTIS HOLDINGS SA
    Inventors: Abhishek Gupta, Herbert Clark Chiou, Samiran De, Franciscus Koppenhagen, Xian-Ming Zeng